AR064765A1 - Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina - Google Patents

Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina

Info

Publication number
AR064765A1
AR064765A1 ARP080100048A ARP080100048A AR064765A1 AR 064765 A1 AR064765 A1 AR 064765A1 AR P080100048 A ARP080100048 A AR P080100048A AR P080100048 A ARP080100048 A AR P080100048A AR 064765 A1 AR064765 A1 AR 064765A1
Authority
AR
Argentina
Prior art keywords
atom
cannabinoid
group
compounds
optionally substituted
Prior art date
Application number
ARP080100048A
Other languages
English (en)
Spanish (es)
Inventor
Josephus H M Lange
Cornelis G Kruse
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR064765A1 publication Critical patent/AR064765A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP080100048A 2007-01-10 2008-01-07 Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina AR064765A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07100323 2007-01-10

Publications (1)

Publication Number Publication Date
AR064765A1 true AR064765A1 (es) 2009-04-22

Family

ID=38069361

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100048A AR064765A1 (es) 2007-01-10 2008-01-07 Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina

Country Status (6)

Country Link
CN (1) CN101809000A (pt)
AR (1) AR064765A1 (pt)
BR (1) BRPI0806452A2 (pt)
MX (1) MX2009007405A (pt)
SA (1) SA08280759B1 (pt)
TW (1) TW200845963A (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5946192B2 (ja) * 2010-11-18 2016-07-05 ジェンリン ディスカバリーJenrin Discovery 肥満症及び糖尿病を含む代謝性疾患の処置に有用なカンナビノイド受容体拮抗薬/逆作動薬
CN104666291A (zh) * 2013-11-26 2015-06-03 山东绿叶制药有限公司 去甲基文拉法辛苯甲酸酯类化合物在制备改善性功能障碍药物中的应用
KR20230116950A (ko) * 2016-05-25 2023-08-04 미쓰비시 타나베 파마 코퍼레이션 불안 장애를 치료하기 위한 (2S)-1-[4-(3,4-디클로로페닐)피페리딘-1-일]-3-[2-(5-메틸-1,3,4-옥사디아졸-2-일)벤조[b]푸란-4-일옥시]프로판-2-올또는 그의 대사산물
KR102036909B1 (ko) * 2017-11-28 2019-10-25 한국과학기술원 신규 디스토니아 치료용 약학적 조성물
GB2591937B (en) 2018-09-04 2023-06-07 Minerva Neurosciences Inc Methods of using a phenoxypropylamine compound to treat pain
WO2021155474A1 (en) * 2020-02-06 2021-08-12 London Pharmaceuticals And Research Corporation Cannabinoid sulfate esters, their salts and uses thereof

Also Published As

Publication number Publication date
CN101809000A (zh) 2010-08-18
SA08280759B1 (ar) 2011-05-04
BRPI0806452A2 (pt) 2011-09-06
TW200845963A (en) 2008-12-01
MX2009007405A (es) 2009-07-17

Similar Documents

Publication Publication Date Title
AR064765A1 (es) Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina
ES2421454T3 (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematológicas
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
DK1940789T3 (da) Fremgangsmåder og forbindelser til fremstilling af CC-1065-analoger
AR077695A1 (es) Derivados de pirimidina como inhibidores del factor ixa
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
AR059064A1 (es) Compuestos de tiazol, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades mediadas por la proteina quinasa b(pkb), tales como cancer.
CO6260089A2 (es) Activadores de guanilato ciclasas solubles
CO6160291A2 (es) Compuestos que modulan al receptor cb2
AR062209A1 (es) Pirazolopirimidinas moduladoras de receptores de glutamato metabotropicos mglur5, proceso para su preparacion, medicamentos que las contienen y usos en la prevencion y/o tratamiento de trastornos neurologicos agudos y cronicos.
AR082799A1 (es) Derivados de quinolina y quinoxalina como inhibidores de quinasa
PE20070832A1 (es) Derivados de piridazinona como inhibidores de la tirosina quinasa
AR058124A1 (es) Derivados de ftalazinona como inhibidores de parp-1
ECSP10010060A (es) Derivados de pirazol sustituídos
CO5550472A2 (es) Piperazinas heterociclicas sustituidas para el tratamiento de la esquizofrenia
RS52261B (en) AMIDOPHENOX INDASOLS AS A USEFUL C-MET INHIBITOR
ES2662444T3 (es) Derivado de piridina
CO6251263A2 (es) Derivados de bencimidazol e indol sustutuidos por oxadiazol y oxazol como inhibidores de dgat1
CO6150142A2 (es) Bezoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
CO6260077A2 (es) Pirimidinas biciclicas fusionadas
EA200700758A1 (ru) Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ
AR099495A1 (es) Derivados de amida, antagonistas de orexina
CY1110464T1 (el) Παραγωγα πυραζολοπυριδινης ως αναστολεις του βητα-αδρενεργικου υποδοχεα της κινασης1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal